Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Consider the vascular system
doi: 10.5497/wjp.v11.i3.27 Adejoke Yetunde Onaolapo, Department of Anatomy, Ladoke Akintola University of Technology, Oyo State 234, Nigeria Hameed Sulaiman, Anthony Tope Olofinnade, Olakunle James Onaolapo, Department of Pharmacology, Ladoke Akintola University of Technology, Oyo State 234, Nigeria ORCID number: Adejoke Yetunde Onaolapo (0000-0001-7126-7050)
/ Clinical Insights Poster: Impact of Point-of-Sale Duplicate Therapy Safety Alert on Concomitant DPP-4 Inhibitor and GLP-1 Agonist Use Key Findings Duplicate therapy point-of-sale edits can be an effective means of reducing the concomitant use of a GLP-1 agonist and DPP-4 inhibitor
This is linked to the biological nature of obesity and the mechanisms Wegovy influences
US$ 20.91
US$ 27.90
US$ 29.01
US$ 27.15
US$ 23.40
US$ 28.61
